Novartis counts cost of exit from drugs vaccine business     

Novartis premises in Ringaskiddy

Novartis lowered its 2020 sales outlook after a second-quarter fall as the Swiss drugmaker counts the cost of exiting the vaccine market six years ago.

Novartis employs about 1,200 people in Ireland but said late last year it plans to cut 320 jobs at part of its Ringaskiddy facility in Cork over two years.